Indeed, this enzyme is considered a possible target for anti‐resorptive drugs 55 and for anabolic therapies for osteoporosis 52, 53, 56; reduced SIRT1 expression has been associated with osteoporotic hip fracture 57. This evidence concerns the gene SIRT1 and osteoporosis.